AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05885828 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Plant-based diet
Description: After wearing CGM on Day 1, participants will be asked to follow the plant-based diet in next 30 days.
Study NCT05885828 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional diabetic diet
Description: Volunteers will be asked to have a diet following 2023 Chinese Diabetes Society guidelines in next 30 days.
Study NCT05885828 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Follow-up visit every 1-2 years
Description: Participants will be visited every 1-2 years. At each visit, face-to-face interviews, specimen collection, anthropometric measurements, ultrasonography evaluation, laboratory tests, and multi-omics data will be conducted.
Study NCT05224401 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pivmecillinam and amoxicillin/clavulanic acid
Description: 1 tablet pivmecillinam 400 mg and 1 tablet Amoxicillin/clavulanic acid 875/125 mg, three times daily.
Study NCT05224401 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard treatment, ciprofloxacin, trimethoprim/sulfamethoxazole or ertapenem depending on susceptibility
Description: Ciprofloxacin 500 mg twice daily, trimethoprim/sulfamethoxazole 800 mg/160 mg twice daily or ertapenem 1 g once daily.
Study NCT05752435 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: COMPARISON OF THERAPEUTIC EFFICACY BETWEEN INTRALESIONAL BLEOMYCIN AND CRYOTHERAPY IN PLANTAR WARTS
Description: comparison of therapeutic efficacy between intralesional bleomycin and cryotherapy in plantar warts
Study NCT06534931 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High velocity low amplitude thoracic spine manipulation
Description: Participants were supine on a treatment table. The chiropractor determined levels of apparent spinal dysfunction by means of static palpation. Participants were then asked to curl forward and bring their knees to their chest as the chiropractor placed a fist just inferior to the targeted level, anywhere between the T4 - T10 vertebrae. The participant was instructed to inhale and then exhale, at which point the chiropractor lowered the participant's torso back to the table and delivered a thrust using his body into his fist.
Study NCT06534931 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: A previously validated physiologically inert manual procedure to the thoracic spine
Study NCT04234555 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Corticomotor excitability to the pelvic floor muscles
Description: Transcranial magenetic stimulation will be used to probe the excitability of cortical projections to the pelvic floor muscles. The outcomes of interest will include motor evoked potential amplitude and silent period.
Study NCT04234555 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Pelvic floor muscle response to pressure applied at the vulvar vestibule
Description: Electromyography will be used to determine whether the pelvic floor muscles (PFMs) respond to pressure applied to the vulvar vestibule as anticipatory (i.e. PFMs are active before the pressure is applied) and as behavioural (i.e. PFMs are active after the pressure is applied) responses. The amplitude of the EMG responses will also be recorded.
Study NCT03852420 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LUMINIZE RF Balloon Catheter
Description: Ablation Therapy with the LUMINIZE RF Balloon Catheter
Study NCT06088667 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fascial mobilization group
Description: In addition to the rehabilitation given to the control group, the fascial release group will be treated with the Graston device to the superficial and deep fascia of the neck and shoulder muscles, biceps and triceps brachii muscles and forearm compartments for 4 weeks.
Study NCT06645119 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: SHAM_COMPARATOR
Intervention: Whey Protein Supplement
Description: Examining the independent effect of post-exercise dietary protein ingestion on bone metabolic markers.
Study NCT06645119 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Whey Protein Supplement
Description: Examining the independent effect of post-exercise dietary protein ingestion on bone metabolic markers.
Study NCT05971355 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LimpiAD cream 2,5% plus
Description: A topical formulation that contains Hyaluronic Acid conjugated with a bacterial wall fragment of Cutibacterium species (HAc-40) and an emollient base. LimpiAD exerts its post-biotic action through the seizure/ trapping and inactivation of catabolites and / or toxins produced by S. aureus as well as protecting the hydrolipidic film, especially in case of dryness, itching, and, in conditions of altered microbiome
Study NCT05971355 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Vehicle
Description: Vehicle of LimpiAD cream 2.5 % plus which has the qualities of an emollient technically enriched with active ingredients known for their use in AD (plus emollient) - having the same ingredients of LimpiAD 2.5% Plus cream but without the HAc-40 component.
Study NCT05971355 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Emollient
Description: Standard emollient used as neutral control, having only a moisturizing and skin barrier action, which represents the basic standard treatment (basic therapy) of atopic dermatitis according to the European Guidelines.
Study NCT05425264 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tele-exercise
Description: Exercise training 2x/week at home. Sessions include circuit exercises of aerobic and resistive training stations which are led remotely.
Study NCT06245109 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duloxetine
Description: 60 mg, oral
Study NCT06245109 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Celecoxib
Description: 200 mg, oral
Study NCT06245109 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo, oral
Study NCT05994092 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Voluntary Isocapnic Hyperpnea
Description: The protocol of 3' of breathing with 20 breaths·min-1 frequency. The Isocapnic BreathWayBetter devices (Isocapnic Technologies Inc, Kelowna, Canada) with 6-liter bags were used. The protocol was performed in a seating position.
Study NCT05644080 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA I&T
Description: Patients demonstrating a high tumor uptake of 68Ga-PSMA on the diagnostic PET/MRI examination in the screening part of the study are eligible for a standard of 3 cycles, with a possible extension to maximum number of 6 cycles, of 177Lu-PSMA radionuclide therapy sessions. SPECT/CT will be performed after each cycle of treatment for dosimetry calculations, while 68Ga-PSMA PET/MRI, quality-of-life schemes and clinical examinations will be used to monitor therapeutic effects during the therapy cycles and up to 1.5 year after treatment initiation. The main endpoints of the study are progression-free survival and overall survival.
Study NCT04987983 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental SLP-R
Description: SLP-R will be given to the infant during bottle-feeding.
Study NCT04987983 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental SLP-L
Description: SLP-L will be given to the infant during bottle-feeding.
Study NCT04234555 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Pressure pain threshold (PPS)
Description: A custom vulvalgesiometer will be used to determine the mean pressure at which participants first report pain at the posterior vaginal fourchette.
Study NCT04234555 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Temporal summation of pain
Description: A custom vulvalgesiometer will be used to apply the same pressure (rated as 4/10 duiring PPS testing as described above) to the vulvar vestibule across 10 repetitions. The difference in pain rated on the tenth application and that rated on the first application will be the outcome.
Study NCT04234555 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Tonic, phasic and reflex activation of the pelvic floor muscles (PFMs)
Description: Electromyography will be used to measure the mean smoothed, rectified activation amplitude across 1 second of complete rest, across three maximal effort PFM contractions, and across three attempts at a bearing down maneuver.
Study NCT04950153 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Peer navigation
Description: Peer navigators will navigate youth with HIV to provide assistance and support to optimize adherence to antiretroviral treatment (ART)
Study NCT04950153 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: SMS Text messaging
Description: Short Message System (SMS) text messages to remind and encourage youth to adhere to their ART
Study NCT04950153 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Social Media Engagement
Description: HIV testing outreach using social media platforms to promote HIV testing.
Study NCT04950153 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Testing Peer Navigation
Description: Peer navigators will conduct HIV testing outreach and linkage to care to at-risk youth
Study NCT05470166 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine IV
Description: lidocaine infusion as bolus 1.5mg/kg then 2mg/kg/hr
Study NCT05470166 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: saline IV
Description: saline infusion same volume as lidocaine
Study NCT05172297 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent Web
Description: Parent-Web (PW) is internet delivered and rooted in social learning and coercion theory, PW supports parenting practices and parent-child interactions encouraging prosocial behavior and emotion regulation, reduce coercive parenting, improve communication, problem solving, and warmth. PW has a universal and selective edition. Universal PW has 5 basic modules (1 module per week, 6-8 weeks) and bonus modules. Basic modules contain information, exercises, and videos of actors showing parenting practices. A family guide supports parents through modules.
Study NCT05172297 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Parent Web
Description: Parent-Web (PW) is internet delivered and rooted in social learning and coercion theory, PW supports parenting practices and parent-child interactions encouraging prosocial behavior and emotion regulation, reduce coercive parenting, improve communication, problem solving, and warmth. PW has a universal and selective edition. Universal PW has 5 basic modules (1 module per week, 6-8 weeks) and bonus modules. Basic modules contain information, exercises, and videos of actors showing parenting practices. A family guide supports parents through modules.
Study NCT05227326 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PCNA Inhibitor AOH1996
Description: Given PO
Study NCT05468606 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GA2
Description: GA2 sporozoites administered by 50 mosquito bites
Study NCT05468606 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCG
Description: 0.1 mL BCG vaccine intradermally
Study NCT05468606 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: YF-17D (fractional ID dose)
Description: 0.1 mL YF17D vaccine intradermally
Study NCT05468606 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imiquimod
Description: 250mg imiquimod 5% cream topical
Study NCT05468606 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Mock immunization
Description: 50 bites by uninfected mosquitoes
Study NCT05912751 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Exercise Then Foam Roll
Description: Participants in AB will perform the experimental (exercise) intervention first and the control (foam rolling) intervention second.
Study NCT05912751 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Foam Roll Then Exercise
Description: Participants in BA will perform the control (foam rolling) intervention first and the experimental (exercise) intervention second.
Study NCT06183710 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contingency management
Description: Psychosocial intervention
Study NCT04766437 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prasugrel 10mg
Description: Once daily 10 mg prasugrel for 12 months preceded by a loading dose of 60 mg prasugrel at least 2 hours prior to percutaneous coronary intervention without concurrent aspirin therapy.
Study NCT04766437 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor 90mg
Description: Twice daily 90 mg ticagrelor for 12 months preceded by a loading dose of 180 mg ticagrelor at least 2 hours prior to percutaneous coronary intervention without concurrent aspirin therapy.
Study NCT05481294 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transpersonal Supportive Coaching
Description: Coaching is given for four months (two times a month) with a 45-minute duration per coaching by a professional coach
Study NCT05481294 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Support
Description: Standard support is given for four months using a support system provided by Peer Support Foundation
Study NCT05478343 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IM21 CAR-T cells
Description: IM21 CAR-T cells administrated in a dosage to be selected by physician from a specific range.
Study NCT05313932 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sleep deprivation
Description: Participants wake after six hours so that they are deprived of 2 hours of sleep
Study NCT05022771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PMG1015 Dose 1
Description: Dose level 1 of PMG1015
Study NCT05022771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PMG1015 Dose 2
Description: Dose level 2 of PMG1015
Study NCT05022771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PMG1015 Dose 3
Description: Dose level 3 of PMG1015
Study NCT05022771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PMG1015 Dose 4
Description: Dose level 4 of PMG1015
Study NCT05022771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PMG1015 Dose 5
Description: Dose level 5 of PMG1015
Study NCT05022771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PMG1015 Dose 6
Description: Dose level 6 of PMG1015
Study NCT05022771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo to match
Study NCT05279638 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: serum ATG5
Description: This kit is used to assay the Autophagy protein 5(ATG5) in the sample of human's serum, blood plasma, and other related tissue Liquid
Study NCT06570980 — intervention group
Intervention type: DRUG
Intervention: sulfonylurease with metformin, DPP4 inhibitors with Metformin
Description: Oral hypoglycemic agents
Study NCT06539481 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fluocinolone acetonide 190 micrograms
Description: ILUVIEN®, is a tiny tube that is to be implanted in the eye and releases low levels of the corticosteroid (fluocinolone acetonide) in the eye. ILUVIEN® delivers corticosteroid directly to the intended site of action for up to 36 months.
Study NCT06197724 — intervention group
Intervention type: DEVICE
Intervention: Magnetocardiography
Description: Magnetocardiography
Study NCT04321655 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Intensity LASER Therapy (HILT)
Description: The total energy will be delivered to the patient during one session will be 1,250 J through three phases of treatment.~1. Initial phase (710 and 810 mJ (millijoule)/cm2 for a total of 500 J)~2. Intermediate phase (handpiece will be applied on the joint line just proximal to the medial and lateral tibial condyles with 25 J, a fluency of 610 mJ/cm2, and a time of 14 s for each point and a total of 250 J)~3. Final phase (same as the initial phase (500 J) except that scanning will be slow manual scanning ) The application time for all three phases will be approximately 15 min with the total energy delivered to the patient during one session of 1,250 J
Study NCT04321655 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ibuprofen Gel Phonophoresis (IGP)
Description: Continuous ultrasound set at a frequency of 1 MHz and an intensity of 1 W/cm2 was applied on a circular basis. (8 min/ one session each day for 3 days/week for 8 weeks).
Study NCT04321655 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation (tDCS)
Description: Anode electrode -C3/C4 (contralateral side of the most affected knee), Cathode electrode- contralateral supraorbital area. (2 mA intensity for 20 minutes, one session/day for 3 days/week for 8 weeks)
Study NCT04321655 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physiotherapy (CPT)
Description: 1. Warm-up exercises: Walking at the usual speed on a flat surface for 10 min ( 3sets X10 Reps X 3 min rest in between)~2. Hamstring and calf gentle stretches. ( 3sets X10 Reps X 3 min rest in between)~3. Straight leg raise (SLR) ( 3sets X10 Reps X 3 min rest in between)~4. Quadriceps setting ( 3sets X10 Reps X 3 min rest in between)~5. Pillow squeeze ( 3sets X10 Reps X 3 min rest in between)~6. Heel raise ( 3sets X10 Reps X 3 min rest in between)~7. One leg balance ( 3sets X10 Reps X 3 min rest in between)~8. Step ups ( 3sets X10 Reps X 3 min rest in between)~9. Quadriceps strengthening exercises ( 3sets X10 Reps X 3 min rest in between)
Study NCT06645418 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: relative Hand grip strength
Description: To perform this study the relative handgrip strength (rHGS) index was used. The rHGSi is defined as the sum of the handgrip strength of both hands divided by body mass index (BMI), and it is considered a better prognostic tool than handgrip strength. rHGS was measured by Jamar hand dynamometer. The Functional Performance was determined by using 3 tests of the Senior Fitness Test (The 30-second chair stand test, the 8-feet Up-and-Go test, and the 2 minutes' Walk Test).
Study NCT06645418 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: senior fitness test
Description: The Functional Performance was determined by using 3 tests of the Senior Fitness Test (The 30-second chair stand test, the 8-feet Up-and-Go test, and the 2 minutes' Walk Test).
Study NCT06569355 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VCT220
Description: A small molecule GLP-1R agonist tablet, orally administration, once daily
Study NCT06569355 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo tablet
Study NCT06569810 — intervention group
Intervention type: DEVICE
Intervention: Repeated Low-Level Red Light (RLRL) therapy
Description: In our study, we do not implement any interventions; rather, we collect follow-up information from patients who, due to insufficient response to traditional myopia control therapies, have transitioned to Repeated Low-Level Red Light (RLRL) therapy. The data gathered will reflect treatment patterns as per the approved indications for RLRL therapy, where subjects may have undergone treatment sessions twice daily, each lasting for 3 minutes with a minimum interval of 4 hours between sessions. Our analysis will focus on the real-world outcomes, specifically evaluating the proportion of participants who have achieved effective myopia control (defined as AL elongation of less than 0.1mm per year or SER progression of less than 0.25 diopter per year) after 12 months of documented RLRL therapy use among the collected data from eligible subjects.
Study NCT06570005 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Water Quality Assurance Fund
Description: * At the water system level: Written legal agreements between water systems, centralized laboratories, and the organization facilitating the Assurance Fund will provide water systems with regular water quality testing and provide laboratories a guarantee of payments if water systems fail to pay for testing services on time (for up to three concurrent unpaid invoices). Regular debrief meetings will be held with water operators and local government authorities to discuss test results and water treatment options, and to encourage water systems to share water quality information with their consumers. Technical guidance to improve water treatment will be provided, if requested by water system operators or local government authorities.~* At the community level: Community engagement, primarily at the onset, to inform the community about the water quality testing program and answer questions.
Study NCT04819854 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EP395
Description: capsule for oral treatment
Study NCT04819854 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: capsule for oral treatment
Study NCT06565247 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [18F]PSMA-PET
Description: Pre-surgical imaging using \[18F\]PSMA-PET at Umea University Hospital, 3.5 MBq/kg, i.v. injection.
Study NCT06565247 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI sequences optimized for prostate cancer examinations
Description: T2-WI, T1-WI, DCE and DWI at Umea University Hospital and at Skåne University Hospital
Study NCT06607406 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy
Description: 6 fractions per week, BID fractions one day per week
Study NCT06607406 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Conventional radiotherapy
Description: 5 fractions per week, daily M-F